Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series

Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virchows Archiv : an international journal of pathology 1998-07, Vol.433 (1), p.19-27
Hauptverfasser: STREGE, R. J, SAEGER, W, LINKE, R. P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 19
container_title Virchows Archiv : an international journal of pathology
container_volume 433
creator STREGE, R. J
SAEGER, W
LINKE, R. P
description Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.
doi_str_mv 10.1007/s004280050211
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80044582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80044582</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-25babd4407725e952ac4fb2be64c9ac93d4cc7fb318289977387a02c036441843</originalsourceid><addsrcrecordid>eNo9kEtLxDAUhYMo4zi6dClkIe6qebVJ3cn4hAFBdF3SNHUibVJ700UX_nczOLi6h3s-zuJD6JySa0qIvAFCBFOE5IRReoCWVHCWMU7kIVqSUuRZwak8RicAXyQhihYLtCiLkilGl-jn3ulPH8AB1r7Bru8nH7YOYjBb2zujO2w6DeDalKMLHocWwwxxV2Ldz11wTQAL-Ba_2SGMcQcIjo3ePZ1Ps3jyYDtrom2wnmIYYMZgR2fhFB21ugN7tr8r9PH48L5-zjavTy_ru002MJ7HjOW1rhshiJQst2XOtBFtzWpbCFNqU_JGGCPbmlPFVFlKyZXUhBnCCyGoEnyFrv52hzF8TxZi1Tswtuu0t2GCKukTIlcsgRd7cKp721TD6Ho9ztXeV-ov972G5KYdtTcO_rGknSrC-S-duHpt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80044582</pqid></control><display><type>article</type><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>STREGE, R. J ; SAEGER, W ; LINKE, R. P</creator><creatorcontrib>STREGE, R. J ; SAEGER, W ; LINKE, R. P</creatorcontrib><description>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s004280050211</identifier><identifier>PMID: 9692821</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Aged, 80 and over ; Amyloidosis ; Amyloidosis - classification ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Biological and medical sciences ; Female ; Humans ; Immunohistochemistry ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Other metabolic disorders ; Serum Amyloid A Protein - analysis</subject><ispartof>Virchows Archiv : an international journal of pathology, 1998-07, Vol.433 (1), p.19-27</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2301803$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9692821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STREGE, R. J</creatorcontrib><creatorcontrib>SAEGER, W</creatorcontrib><creatorcontrib>LINKE, R. P</creatorcontrib><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amyloidosis</subject><subject>Amyloidosis - classification</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Other metabolic disorders</subject><subject>Serum Amyloid A Protein - analysis</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLxDAUhYMo4zi6dClkIe6qebVJ3cn4hAFBdF3SNHUibVJ700UX_nczOLi6h3s-zuJD6JySa0qIvAFCBFOE5IRReoCWVHCWMU7kIVqSUuRZwak8RicAXyQhihYLtCiLkilGl-jn3ulPH8AB1r7Bru8nH7YOYjBb2zujO2w6DeDalKMLHocWwwxxV2Ldz11wTQAL-Ba_2SGMcQcIjo3ePZ1Ps3jyYDtrom2wnmIYYMZgR2fhFB21ugN7tr8r9PH48L5-zjavTy_ru002MJ7HjOW1rhshiJQst2XOtBFtzWpbCFNqU_JGGCPbmlPFVFlKyZXUhBnCCyGoEnyFrv52hzF8TxZi1Tswtuu0t2GCKukTIlcsgRd7cKp721TD6Ho9ztXeV-ov972G5KYdtTcO_rGknSrC-S-duHpt</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>STREGE, R. J</creator><creator>SAEGER, W</creator><creator>LINKE, R. P</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</title><author>STREGE, R. J ; SAEGER, W ; LINKE, R. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-25babd4407725e952ac4fb2be64c9ac93d4cc7fb318289977387a02c036441843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amyloidosis</topic><topic>Amyloidosis - classification</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Other metabolic disorders</topic><topic>Serum Amyloid A Protein - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STREGE, R. J</creatorcontrib><creatorcontrib>SAEGER, W</creatorcontrib><creatorcontrib>LINKE, R. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STREGE, R. J</au><au>SAEGER, W</au><au>LINKE, R. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><addtitle>Virchows Arch</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>433</volume><issue>1</issue><spage>19</spage><epage>27</epage><pages>19-27</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>9692821</pmid><doi>10.1007/s004280050211</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 1998-07, Vol.433 (1), p.19-27
issn 0945-6317
1432-2307
language eng
recordid cdi_proquest_miscellaneous_80044582
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aged
Aged, 80 and over
Amyloidosis
Amyloidosis - classification
Amyloidosis - metabolism
Amyloidosis - pathology
Biological and medical sciences
Female
Humans
Immunohistochemistry
Male
Medical sciences
Metabolic diseases
Middle Aged
Other metabolic disorders
Serum Amyloid A Protein - analysis
title Diagnosis and immunohistochemical classification of systemic amyloidoses : Report of 43 cases in an unselected autopsy series
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A49%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20immunohistochemical%20classification%20of%20systemic%20amyloidoses%20:%20Report%20of%2043%20cases%20in%20an%20unselected%20autopsy%20series&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=STREGE,%20R.%20J&rft.date=1998-07-01&rft.volume=433&rft.issue=1&rft.spage=19&rft.epage=27&rft.pages=19-27&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s004280050211&rft_dat=%3Cproquest_pubme%3E80044582%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80044582&rft_id=info:pmid/9692821&rfr_iscdi=true